Growth Metrics

Balchem (BCPC) Cost of Revenue (2016 - 2026)

Balchem (BCPC) has disclosed Cost of Revenue for 17 consecutive years, with $21.1 million as the latest value for Q1 2026.

  • For Q1 2026, Cost of Revenue rose 24.64% year-over-year to $21.1 million; the TTM value through Mar 2026 reached $79.5 million, down 61.04%, while the annual FY2025 figure was $75.4 million, 87.79% down from the prior year.
  • Cost of Revenue hit $21.1 million in Q1 2026 for Balchem, up from $20.1 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $565.3 million in Q4 2023 and bottomed at -$430.6 million in Q4 2022.
  • Average Cost of Revenue over 5 years is $66.1 million, with a median of $19.3 million recorded in 2025.
  • On a YoY basis, Cost of Revenue climbed as much as 1036.04% in 2022 and fell as far as 2939.47% in 2022.
  • Balchem's Cost of Revenue stood at -$430.6 million in 2022, then skyrocketed by 231.27% to $565.3 million in 2023, then crashed by 72.81% to $153.7 million in 2024, then tumbled by 86.95% to $20.1 million in 2025, then rose by 5.19% to $21.1 million in 2026.
  • According to Business Quant data, Cost of Revenue over the past three periods came in at $21.1 million, $20.1 million, and $19.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.